Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,310,297
-$1,424,648 QoQ
Shares Held
487,017
-4.8% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#45
of 325 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $214,822,359 across 27 Biotechnology names. PCVX ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,287,558 | $90,965,971 | |
| 2 | CYTK |
Cytokinetics Inc
|
570,664 | $48,614,865 | |
| 3 | PCVX |
Vaxcyte, Inc.
This page
|
487,017 | $28,310,297 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
77,398 | $23,299,119 | |
| 5 | INSM |
INSMED Inc
|
41,694 | $4,445,414 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,562 | $3,756,271 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,274 | $3,288,549 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
35,881 | $2,808,405 |
All Filings in PCVX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,310,297 | 487,017 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,734,945 | 511,701 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,157,917 | 566,925 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $24,384,998 | 676,985 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $18,593,733 | 571,939 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,532,941 | 570,258 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $45,531,267 | 556,209 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $50,740,335 | 444,039 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,728,554 | 367,217 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||